Quantcast
Last updated on April 23, 2014 at 21:24 EDT

Latest hyperglycemia Stories

2013-05-02 08:37:45

The SGLT disease education campaign provides resources for healthcare professionals about the role of sodium glucose co-transporters in maintaining blood sugar balance RIDGEFIELD, Conn. and INDIANAPOLIS, May 2, 2013 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company (NYSE: LLY) today announced the launch of an educational campaign designed to provide healthcare professionals (HCPs) with a greater understanding of the role sodium glucose...

2013-04-15 08:27:58

At rare, extremely high blood glucose levels (1024 mg/dL and above), the FreeStyle InsuLinx Blood Glucose Meter may provide an inaccurate reading ABBOTT PARK, Ill., April 15, 2013 /PRNewswire/ -- Abbott (NYSE: ABT) today announced it is initiating a voluntary recall of FreeStyle InsuLinx(®) Blood Glucose Meters in the United States. The company has determined that at extremely high blood glucose levels of 1024 mg/dL and above, the FreeStyle InsuLinx Meter will display and...

2013-03-21 04:20:50

Industry Thought-Leaders Highlight Paradigm-Shifting Potential of Automated, Bedside Glucose Monitoring System for Critically Ill Patients BRUSSELS, Belgium, March 21, 2013 /PRNewswire/ -- OptiScan Biomedical Corporation, a developer of innovative continuous glucose monitoring systems for use in intensive care units (ICU), today announced that the OptiScanner((TM)), the company's first-of-its-kind automated, bedside glucose monitoring system, was the focus of a special symposium at...

2013-02-28 08:31:23

Predictive Glucose Control System in Development Shows Promising Ability to Minimize Number, Duration and Severity of Hypoglycemic Events with No Safety Concerns WEST CHESTER, Pa., Feb. 28, 2013 /PRNewswire/ -- Animas Corporation announced today positive results from the second phase of human clinical trials of a first-generation, closed-loop insulin delivery system in development, designed to predict a rise or fall in blood glucose and correspondingly increase, decrease, suspend...

Antidepressant Paroxetine Treats Diabetes
2012-12-14 22:05:43

Lee Rannals for redOrbit.com — Your Universe Online Researchers have found the commonly used antidepressant drug paroxetine could become a therapy for the vascular complications of diabetes. The scientists made their discovery after screening 6,766 clinically used drugs and pharmacologically active substances. "We developed this assay and used it to test literally every single existing drug and a good selection of other biologically active compounds," UTMB professor Csaba...

2012-12-01 05:02:36

Published findings recently released by the Group Health Research Institute show that over a third of patients who suffered from type-2 diabetes mellitus would enter full relapse within five years passing from their surgeries. Doctors urge the importance of preventative treatment over the need for such invasive surgeries. Seattle, WA (PRWEB) November 30, 2012 A detailed retrospective report has been comprised by the Group Health Research Institute in hopes of examining the probability of...

2012-11-13 16:26:13

-- The FDA's final artificial pancreas guidance adopts JDRF's recommendations, providing a clear path toward improving lives by moving the transformative technology into the hands of millions with type 1 diabetes -- NEW YORK, Nov. 13, 2012 /PRNewswire-USNewswire/ --JDRF today called the Food and Drug Administration's (FDA) final artificial pancreas guidance a milestone in advancing better treatments for people with type 1 diabetes (T1D)--one of JDRF's key goals. The final FDA guidance...

2012-11-09 04:20:56

BARCELONA, Spain, Nov. 9, 2012 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) today announced that its investigational medicine canagliflozin substantially lowered blood glucose levels compared to placebo when used as add-on therapy in patients with type 2 diabetes who are inadequately controlled with the antihyperglycemic medications metformin and pioglitazone. These results were presented at the 4th World Congress on Controversies to Consensus in Diabetes, Obesity, and...

2012-10-02 02:28:58

BERLIN, Oct. 2, 2012 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) today announced that use of the investigational medicine canagliflozin substantially lowered blood glucose levels when used as add-on therapy in patients on insulin therapy for type 2 diabetes and who are considered to be at greater risk for cardiovascular disease. These results were presented at the 48th European Association for the Study of Diabetes (EASD) Annual Meeting. CANVAS (CANagliflozin...

2012-09-10 11:02:56

NIH-supported findings diverge from previous studies showing that blood sugar control benefits adults Tight blood sugar control in infants and children undergoing heart surgery does not lower the risk of infection or improve recovery, according to a study funded by the National Institutes of Health. Infants and children who have undergone heart surgery commonly develop high blood sugar levels, which may be associated with health issues and death. Although the results of clinical trials...